CNS drug development

Cambridge, Massachusetts, U.S., September 21, 2026 Sensorium Therapeutics, a clinical-stage central nervous system biotechnology company, has announced positive Phase...

Shirley, New York, September 3, 2026 American Regent, Inc. has initiated a voluntary nationwide recall of three lots of...

San Francisco, California, September 3, 2026 Thryv Therapeutics Inc., a clinical-stage biopharmaceutical company developing selective SGK1 inhibitors, has entered...

Stockholm, Sweden, August 18, 2026 AlzeCure Pharma AB has received the full $10 million upfront payment from Eli Lilly...

MUMBAI, India and WARREN, N.J., July 28, 2026 Cipla Limited and its wholly owned subsidiary Cipla USA Inc. have...

BOSTON, TOKYO and SUZHOU, July 28, 2026 CORE Biomedicine, a biotechnology company advancing lineage-based precision oncology therapeutics, has announced...

SALT LAKE CITY, July 28, 2026 Co-Diagnostics, Inc. has announced two significant milestones that strengthen global preparedness against Ebola...

TAIPEI, July 28, 2026 Dasher Neuroscience Holdings Inc. has successfully completed patient enrollment in its global Phase 2 clinical...

Boston, USA & Shanghai, China – March 9, 2026 Rapport Therapeutics and Tenacia Biotechnology have announced a strategic collaboration...

MILWAUKEE, Feb. 22, 2026 — New clinical research presented at the 2026 Annual Meeting of the American Academy of...